Novo stock popped early Wednesday on better-than-expected third-quarter sales and profit thanks to resounding beats from its GLP-1 drugs. The post Novo Surges 5% After Walloping Expectations On The Back Of Its GLP-1 Drugs appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real